附属病院 とちぎ子ども医療センター 小児科

横山 孝二

ヨコヤマ コウジ  (Koji Yokoyama)

基本情報

所属
自治医科大学 附属病院 とちぎ子ども医療センター小児科 准教授

J-GLOBAL ID
201401059606060893
researchmap会員ID
B000238582

外部リンク

研究キーワード

 3

論文

 4
  • 黒崎 雅典, 伊東 岳峰, 安済 達也, 小森 咲子, 別井 広幸, 青柳 順, 齋藤 貴志, 小高 淳, 金井 孝裕, 横山 孝二, 熊谷 秀規, 森本 哲, 山形 崇倫
    日本小児科学会雑誌 120(3) 649 2016年3月  
  • 黒崎 雅典, 伊東 岳峰, 安済 達也, 小森 咲子, 別井 広幸, 青柳 順, 齋藤 貴志, 小高 淳, 金井 孝裕, 横山 孝二, 熊谷 秀規, 森本 哲, 山形 崇倫
    日本小児科学会雑誌 120(3) 649 2016年3月  
  • Koji Yokoyama, Masaharu Takahashi, Tsutomu Nishizawa, Shigeo Nagashima, Suljid Jirintai, Shigeru Yotsumoto, Hiroaki Okamoto, Mariko Y. Momoi
    ARCHIVES OF VIROLOGY 156(9) 1591-1601 2011年9月  査読有り
    A hepatitis C virus (HCV) strain (HC10-0804) recovered from a 12-year-old Japanese female with chronic hepatitis C segregated into discordant genotypes, 2b and 1b, in the 5'UTR/core and NS5B regions, respectively, thus suggesting an inter-genotypic recombination. The HC10-0804 isolate had a genomic length of 9,423 nucleotides (nt), excluding the poly(U) tract at the 3' terminus, and encoded a single open reading frame (ORF) for a polyprotein of 3,014 amino acids (aa). Based on Simplot and Bootscan analyses, the crossover point from 2b to 1b was estimated at nt 3443/3444 (aa 1034/1035), just after the beginning of the NS3 region. Comparison of the entire genomic sequence showed that the HC10-0804 strain was only 90.2% identical to the previously reported 2b/1b recombinant strain (SE-03-07-1689) from the Philippines, whose putative crossover point was 24 nt downstream of that of HC10-0804. These results indicate the circulation of a novel inter-genotypic (2b/1b) recombinant HCV in Japan.
  • Koji Yokoyama, Naoto Takahashi, Yukari Yada, Yasunori Koike, Ryou Kawamata, Ritei Uehara, Yumi Kono, Yoko Honma, Mariko Y. Momoi
    EARLY HUMAN DEVELOPMENT 86(3) 187-191 2010年3月  査読有り
    Background: Magnesium sulfate (MgSO(4)) has been used as a tocolytic agent in cases of refractory preterm labor. Prolonged maternal administration of MgSO(4) may induce bone demineralization in the neonate. However, the effects of MgSO(4) on serum biochemistry related to bone metabolism in neonates remain unclear. Aim: To assess the effects of prolonged maternal administration of MgSO(4) on fetuses and neonates. Study design: This retrospective case-control study examined 167 neonates. Cases comprised 58 neonates whose mothers had received intravenous MgSO(4) administration for > 5 days. Neonatal serum levels of magnesium (Mg), calcium (Ca), phosphorus (P) and alkaline phosphatase (ALP) were reviewed. We also investigated whether subject neonates showed appearance of osteopenia at the metaphyseal lines on radiography at birth. Results: Mean serum Mg and P levels were significantly higher, and Ca levels were significantly lower, in cases than in controls at birth. Mean serum ALP level was 1188.5 IU/l in cases, significantly higher than that in controls at birth. Bone abnormalities were noted on radiography in 2 subjects. By 3 weeks old, serum ALP levels did not differ significantly between cases and controls. Logistic regression analysis revealed maternal administration of MgSO(4) and multiple pregnancies were significantly related to serum ALP level in neonates at birth. Conclusion: Prolonged maternal administration of MgSO(4) significantly affects neonatal serum biochemistry related to bone metabolism. Potential long-term adverse effects on neonates and how Mg affects fetal bone metabolism in utero need to be investigated in future studies. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

MISC

 29